1-9 of 9
Rita Maduike
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ten-Day Decitabine with Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score Matched Analysis

Abhishek Maiti, MBBS, Courtney D. DiNardo, MD MSCE, Tapan M. Kadia, MD, Elias Jabbour, MD, Caitlin R. Rausch, PharmD, Naval Daver, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Nicholas J. Short, MD, Musa Yilmaz, MD, Yesid Alvarado, MD, Kathryn S Montalbano, RN, Allison Wade, Rita Maduike, Julio A Guerrero, RN, Kenneth Vaughan, RN, Carol A. Bivins, RN, Sherry A. Pierce, BSN, BA, Farhad Ravandi, MBBS, Hagop M. Kantarjian, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–33.
https://doi.org/10.1182/blood-2020-138375
Published: 2020
Journal Articles

AZA + Glutaminase Inhibition with Telaglenastat (CB-839) for Advanced MDS: An Updated Interim Analysis

Kapil Saxena, MD, Marina Konopleva, MD PhD, Tushar D Bhagat, PhD, Veronica A Guerra, MD, Rita Maduike, Stefano Tiziani, PhD, Gautam Borthakur, MD, Elias Jabbour, MD, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Nicholas J. Short, MD, Jan A. Burger, MD PhD, Steven M. Kornblau, MD, Naval Daver, MD, Kiran Naqvi, MD MPH, Tianyu Cai, PhD, Vinitha Mary Kuruvilla, MSc, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Amit Verma, MBBS, Courtney D. DiNardo, MD MSCE
Journal: Blood
Blood (2020) 136 (Supplement 1): 31–32.
https://doi.org/10.1182/blood-2020-137266
Published: 2020
Journal Articles

Outcomes in Molecular Subgroups and Resistance Patterns with Ten-Day Decitabine and Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia

Abhishek Maiti, MBBS, Caitlin R. Rausch, PharmD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Gautam M. Borthakur, MD, Kiran Naqvi, MDMPH, Maro Ohanian, DO, Nicholas J. Short, MD, Yesid Alvarado, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Musa Yilmaz, MD, Nitin Jain, MD, Steven M. Kornblau, MD, Koji Sasaki, MD, Michael Andreeff, MD PhD, Prithviraj Bose, MD, Alessandra Ferrajoli, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Lucia Masarova, MD, Michael E. Rytting, MD, Philip A. Thompson, MBBS, Sa A Wang, MD, Sergej Konoplev, Zhining Chen, Maitrayee Goswami, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, Helen Ma, MS, Carol A. Bivins, RN, Allison Wade, Shadiat L Adewale, Susan Tse, Robin Thomas, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Keyur P. Patel, MBBS, PhD, Hagop M. Kantarjian, MD, Marina Y Konopleva, MD PhD, Courtney D. DiNardo, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 645.
https://doi.org/10.1182/blood-2019-128547
Published: 2019
Journal Articles

Ten-Day Decitabine with Venetoclax (DEC10-VEN) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Abhishek Maiti, MBBS, Courtney D. DiNardo, MDMSc, Caitlin R. Rausch, PharmD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Gautam M. Borthakur, MD, Kiran Naqvi, MDMPH, Maro N. Ohanian, DO, Nicholas J. Short, MD, Yesid Alvarado, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Musa E. Yilmaz, MD, Nitin Jain, MD, Steven M. Kornblau, MD, Koji Sasaki, MD, Michael Andreeff, MD PhD, Prithviraj Bose, MD, Alessandra Ferrajoli, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Lucia Masarova, MD, Michael E. Rytting, MD, Philip A. Thompson, MBBS, Sa A Wang, MD, Sergej Konoplev, Zhining Chen, Maitrayee Goswami, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, Helen Ma, MS, Carol A. Bivins, RN, Allison Wade, Shadiat L Adewale, Susan Tse, Robin Thomas, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Hagop M. Kantarjian, MD, Marina Y Konopleva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2637.
https://doi.org/10.1182/blood-2019-127803
Published: 2019
Journal Articles

Outcomes of Relapsed or Refractory Acute Myeloid Leukemia after Frontline Hypomethylating Agent with Venetoclax Regimens

Abhishek Maiti, MBBS, Caitlin R. Rausch, PharmD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Gautam M. Borthakur, MD, Kiran Naqvi, MDMPH, Maro Ohanian, DO, Nicholas J. Short, MD, Yesid Alvarado, MD, Christopher B. Benton, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Musa E. Yilmaz, MD, Nitin Jain, MD, Steven M. Kornblau, MD, Guillermo Montalban Bravo, MD, Koji Sasaki, MD, Michael Andreeff, MD PhD, Prithviraj Bose, MD, Alessandra Ferrajoli, MD, Ghayas C. Issa, MD, Elias Jabbour, MD, Lucia Masarova, MD, Michael E. Rytting, MD, Philip A. Thompson, MBBS, Sa A Wang, MD, Sergej Konoplev, Zhining Chen, Maitrayee Goswami, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, Helen Ma, MS, Carol A. Bivins, RN, Allison Wade, Shadiat L Adewale, Susan Tse, Robin Thomas, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Hagop M. Kantarjian, MD, Marina Y Konopleva, MD PhD, Courtney D. DiNardo, MD MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 738.
https://doi.org/10.1182/blood-2019-128909
Published: 2019
Journal Articles

Addition of Gemtuzumab Ozogamicin (GO) to Fludarabine, Cytarabine and G-CSF (FLAG) Based Induction Regimen Results in Better Early Molecular Response and Relapse Free Survival Compared to Idarubicin (FLAG-Ida) in Newly Diagnosed Core Binding Factor Leukemia

Gautam Borthakur, MD, Jorge E. Cortes, MD, Guillermo Garcia-Manero, MD, Keyur Patel, MD PhD, Farhad Ravandi, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Naval G. Daver, MD, Musa Yilmaz, MD, Zeev E. Estrov, MD, Maro N. Ohanian, DO, Rita Maduike, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3993.
https://doi.org/10.1182/blood-2018-99-118591
Published: 2018
Journal Articles

Interim Analysis of Phase II Study of Venetoclax with 10-Day Decitabine (DEC10-VEN) in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Abhishek Maiti, MBBS, Courtney D. DiNardo, MDMSc, Jorge E. Cortes, MD, Gautam Borthakur, MD, Naveen Pemmaraju, MD, Christopher B. Benton, MD, Tapan M. Kadia, MD, Koichi Takahashi, MD, Kiran Naqvi, MDMPH, Farhad Ravandi, MD, Yesid Alvarado, MD, Nicholas J Short, MD, Naval G. Daver, MD, Koji Sasaki, MD, Maro N. Ohanian, DO, Guillermo Garcia-Manero, MD, Philip A. Thompson, MBBS, Steven M. Kornblau, MD, Lucia Masarova, MD, Nitin Jain, MD, Elias J. Jabbour, MD, Michael Andreeff, MD PhD, Rita Maduike, Julio A Guerrero, RN, Qi Zhang, PhD, Antonio Cavazos, MSc, Helen Ma, MS, Caitlin R. Rausch, PharmD, Carol A. Bivins, RN, Kenneth Vaughan, RN, Sherry A. Pierce, BSN, BA, Jing Ning, PhD, Wei Qiao, PhD, John S. Welch, MD PhD, Hagop M. Kantarjian, MD, Marina Y. Konopleva, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 286.
https://doi.org/10.1182/blood-2018-99-113749
Published: 2018
Journal Articles

Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)

Prajwal Boddu, MD, Christopher Gurguis, MS, Jorge E. Cortes, MD, Mary Akosile, Farhad Ravandi, MBBS, David Sanford, MD, Mark Brandt, BS, Rita Maduike, Tapan Kadia, MD, Hagop M. Kantarjian, MD, Gautam Borthakur, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 27.
https://doi.org/10.1182/blood.V130.Suppl_1.27.27
Published: 2017
Journal Articles

Clofarabine Plus Low-Dose Cytarabine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome (MDS) Who Have Been Relapsing after, or Are Refractory to, Hypomethylating Agent (HMA) Therapy

Elias J. Jabbour, MD, Hagop M. Kantarjian, MD, Koji Sasaki, MD, Tapan M. Kadia, MD, Farhad Ravandi, MD, Jorge E. Cortes, MD, Joseph D Khoury, MD, Keyur P. Patel, MDPhD, Carlos E. Bueso-Ramos, MD PhD, Naval G. Daver, MD, Gautam Borthakur, MD, Nitin Jain, MD, Courtney D DiNardo, MD, Marina Konopleva, MD PhD, Srdan Verstovsek, MD PhD, Naveen Pemmaraju, MD, Zeev Estrov, MD, Darla Miller, Rita Maduike, RN, Stefan Faderl, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2016) 128 (22): 3166.
https://doi.org/10.1182/blood.V128.22.3166.3166
Published: 2016